SCYNEXIS Inc logo

SCYNEXIS Inc

$ 2.55 +0.11 (+4.51%) 10:08 PM EST
P/E:
At Loss
P/B:
1.81
Market Cap:
$ 83.26M
Enterprise V:
$ 9.01M
Volume:
79.68K
Avg Vol (2M):
105.36K
Also Trade In:
Volume:
79.68K
Market Cap $:
83.26M
PE Ratio:
At Loss
Avg Vol (2-Month):
105.36K
Enterprise Value $:
9.01M
PB Ratio:
1.81
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains.
Name Current Vs Industry Vs History
Cash-To-Debt 2.47
Equity-to-Asset 0.34
Debt-to-Equity 1.06
Debt-to-EBITDA -0.99
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.58
Distress
Grey
Safe
Beneish M-Score -3.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 69.4
9-Day RSI 55.35
14-Day RSI 51.88
6-1 Month Momentum % -36.29
12-1 Month Momentum % -51.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.85
Quick Ratio 7.81
Cash Ratio 7.41
Days Inventory 389.86
Days Sales Outstanding 138.18
Days Payable 5181.55

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -81.5

Financials (Next Earnings Date:2022-11-10 Est.)

SCYX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SCYX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.123
EPS (TTM) ($) -1.66
Beta 1.26
Volatility % 75.85
14-Day RSI 51.88
14-Day ATR ($) 0.158802
20-Day SMA ($) 2.5525
12-1 Month Momentum % -51.39
52-Week Range ($) 1.7 - 8.1
Shares Outstanding (Mil) 32.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SCYNEXIS Inc Filings

Document Form Filing Date
No Filing Data

SCYNEXIS Inc Analysis

Share your research

Headlines

See More
No news.